60
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Invasive Group A Streptococcal Infections in Sweden in 1994 and 1995: Epidemiology and Clinical Spectrum

Pages 609-614 | Published online: 08 Jul 2009

REFERENCES

  • Gothenburg Society of Medicine, Annual Report, 1870, In: Öberg L. Göteborgs Läkaresällskap. En historik; Rundqvists boktryckeri Göteborg 1983. (In Swedish).
  • Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992; 14: 298–307.
  • Högberg U. Effect of introduction of sulphonamides on the incidence of and mortality from puerperal sepsis in a Swedish county hospital. Scand J Infect Dis 1994; 26: 233–8.
  • Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2–13.
  • Martin PR, Høiby EA. Streptococcal serogroup A epidemic in Norway 1987–1988. Scand J Infect Dis 1990; 22: 421–9.
  • Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiological and clinical study. J Infect Dis 1991; 164: 595–8.
  • Høiby EA. Økt insidens av alvorlige gruppe A-streptokokkin-feksjoner i Norge de siste ti år. Nytt utbrudd 1993–94. Tidskr Nor Lægeforen 1995; 115: 3131–6.
  • Public Health Laboratory Service. Invasive group A streptococcal infections in Gloucestershire. Communicable Disease Report. 1994; 4: 97.
  • Chelsom J, Halstensen A, Haga T, Høiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344: 1111–5.
  • The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. JAMA 1993; 269: 390–1.
  • Eriksson BKG, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Inf Dis 1998; 27: 1428–36.
  • Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. and the Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335: 547–54.
  • Andersen MM, Rønne T. Group A streptococcal bacteraemias in Denmark 1987–89. J Infect 1995; 31: 33–7.
  • Österlund A. Epidemiological observations on Streptococcus pyogenes serotype T1 in Uppsala county, Sweden 1989–1995. APMIS 1996; 104: 168 70.
  • Claesson BEB, Svensson N, Gotthardsson L, Gotthardsson L, Gärdén B. A foodborne outbreak of group A streptococcal disease at a birthday party. Scand J Infect Dis 1992; 24: 577–86.
  • Breathnach AS, Eykyn SJ. Streptococcus pyogenes bacter-aemia: A 27-year study in a London teaching hospital. Scand J Infect Dis 1997; 29: 473–8.
  • Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980–1990 and their association with disease. J Med Microbiol 1993; 39: 165–78.
  • Stevens DL. Review: Invasive group A streptococcal disease. Inf Agents Dis 1996; 5: 157–66.
  • Bucher A, Martin PR, Høiby EA, Halstensen A, Ødegaard A, Hellum KB, et al. Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur J Clin Microbiol Infect Dis 1992; 11: 416–46.
  • Livni G, Ashkenazi S, Leibovici L, Pitlik S, Lev B, Konis-berger H, et al. Incidence and severity of group A streptococcal bacteremia in a medical center in Israel, 1981–1994. Scand J Infect Dis 1996; 28: 139–42.
  • Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176: 992–1000.
  • Keefer CS, Ingelfinger FJ, Spink WW. Significance of hemolytic streptococcic bacteremia. Arch Intern Med 1937; 60: 1084–97.
  • Centers for Disease Control and Prevention. Outbreak of invasive group A streptococcus associated with varicella in a childcare center-Boston Massachusetts. Morb Mortal Wkly Rep 1997; 46: 944–8.
  • Givner LB. Invasive disease due to group A beta-hemolytic streptococci: continued occurrence in North Carolina. South Med J 1998; 91: 333–7.
  • Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med 1959; 110: 271–92.
  • Norgren M, Norrby A, Holm SE. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis 1992; 166: 1014–20.
  • Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518–21.
  • Musser JM, Kapur V, Kanjilal S, Shah U, Musher DM, Barg NL, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993; 167: 337–46.
  • Eriksson BKG, Andersson J, Holm SE, Norgren M. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk for the streptococcal toxic shock syndrome. J Infect Dis 1999; 180: 410–8.
  • Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNFα and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis 1995; 27: 125–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.